• Persistent Asset Partners Ltd Takes Position in Protagonist Therapeutics, Inc. $PTGX MarketBeat Mon, 17 Nov 2025 13:25:19 GMT
• Protagonist Therapeutics, Inc. $PTGX Shares Purchased by Bank of New York Mellon Corp MarketBeat Mon, 17 Nov 2025 09:27:01 GMT
• A Valuation Check on Protagonist Therapeutics (PTGX) After Sharply Widened Quarterly Losses simplywall.st Mon, 17 Nov 2025 05:26:59 GMT
• Is Protagonist Therapeutics Inc. stock cheap compared to fundamentals - Treasury Yields & Real-Time Chart Pattern Alerts newser.com Sun, 16 Nov 2025 21:36:39 GMT
• H.C. Wainwright Reaffirms Their Buy Rating on Protagonist Therapeutics (PTGX) The Globe and Mail Sat, 15 Nov 2025 23:52:39 GMT
• Do Protagonist Therapeutics’ (PTGX) Widening Losses Signal a Strategic Shift or a Temporary Setback? simplywall.st Sat, 15 Nov 2025 20:23:07 GMT
• How Protagonist Therapeutics Inc. stock reacts to job market data - Market Movement Recap & AI Powered Market Entry Strategies newser.com Sat, 15 Nov 2025 19:45:37 GMT
• Is Protagonist Therapeutics Inc. stock entering bullish territory - Earnings Beat & Reliable Price Breakout Signals newser.com Sat, 15 Nov 2025 16:26:46 GMT
• Protagonist Therapeutics, Inc. $PTGX Stock Holdings Trimmed by Aviva PLC MarketBeat Sat, 15 Nov 2025 08:59:15 GMT
• Protagonist Therapeutics, Inc. $PTGX Shares Purchased by Jupiter Asset Management Ltd. MarketBeat Fri, 14 Nov 2025 14:09:58 GMT
• is protagonist therapeutics inc. stock cheap compared to fundamentals - product launch & stepwise entry/exit trade alerts newser.com Fri, 14 Nov 2025 05:10:04 GMT
• Protagonist Therapeutics Inc. stock chart pattern explained - 2025 Trading Recap & Reliable Volume Spike Trade Alerts newser.com Thu, 13 Nov 2025 17:37:23 GMT
• 135,050 Shares in Protagonist Therapeutics, Inc. $PTGX Purchased by Nan Fung Trinity HK Ltd. MarketBeat Thu, 13 Nov 2025 12:20:16 GMT
• Profund Advisors LLC Has $1.05 Million Stock Holdings in Protagonist Therapeutics, Inc. $PTGX MarketBeat Thu, 13 Nov 2025 11:43:43 GMT
• We Think You Can Look Beyond Protagonist Therapeutics' (NASDAQ:PTGX) Lackluster Earnings 富途牛牛 Thu, 13 Nov 2025 10:03:42 GMT
• protagonist announces icotrokinra phase 2b anthem-uc trial data to be presented at the united european gastroenterology week berli... Central New Jersey News Thu, 13 Nov 2025 09:49:38 GMT
• How strong is Protagonist Therapeutics Inc. stock revenue growth - Earnings Trend Report & Daily Profit Maximizing Tips newser.com Wed, 12 Nov 2025 23:20:21 GMT
• is protagonist therapeutics inc. stock cheap compared to fundamentals - july 2025 sector moves & weekly market pulse updates newser.com Wed, 12 Nov 2025 20:32:47 GMT
• Protagonist Announces New Icotrokinra Data in Ulcerative Colitis and Plaque Psoriasis Presented at Two Recent Medical Conferences Pocono Record Wed, 12 Nov 2025 15:23:16 GMT
• protagonist therapeutics, inc. experiences revision in its stock evaluation amid strong market performance Markets Mojo Wed, 12 Nov 2025 08:38:15 GMT
• Protagonist Therapeutics Announces Oral and Poster Presentations on Rusfertide at the 67th Annual ASH Meeting Massillon Independent Tue, 11 Nov 2025 23:40:29 GMT
• Protagonist Therapeutics (NASDAQ:PTGX) Price Target Raised to $98.00 at Citigroup MarketBeat Tue, 11 Nov 2025 22:29:33 GMT
• Protagonist Reports Third Quarter 2025 Financial Results and Provides Corporate Update The Marion Star Tue, 11 Nov 2025 13:48:18 GMT
• Citigroup Maintains Protagonist Therapeutics (PTGX) Buy Recommendation Nasdaq Tue, 11 Nov 2025 12:04:00 GMT
• how protagonist therapeutics inc. stock responds to policy changes - wall street watch & verified momentum stock watchlist newser.com Tue, 11 Nov 2025 10:01:32 GMT
• Protagonist Therapeutics, Inc. (NASDAQ:PTGX) Given Average Rating of "Moderate Buy" by Analysts MarketBeat Tue, 11 Nov 2025 09:31:57 GMT
• Is Protagonist Therapeutics Fairly Priced After Clinical Trial Updates and Big Share Price Surge? simplywall.st Tue, 11 Nov 2025 00:29:53 GMT
• protagonist reports third quarter 2025 financial results and provides corporate update The Palm Beach Post Mon, 10 Nov 2025 23:28:24 GMT
• ptgx: citigroup raises price target, maintains 'buy' rating | pt GuruFocus Mon, 10 Nov 2025 22:35:22 GMT
• Protagonist Therapeutics price target raised to $65 from $47 at Goldman Sachs TipRanks Mon, 10 Nov 2025 13:28:13 GMT
• protagonist therapeutics, inc. experiences revision in its stock evaluation amid strong market performance Markets Mojo Mon, 10 Nov 2025 13:24:59 GMT
• citi maintains protagonist therapeutics(ptgx.us) with buy rating, raises target price to $98 富途牛牛 Mon, 10 Nov 2025 12:34:00 GMT
• is protagonist therapeutics inc. stock cheap compared to fundamentals - july 2025 update & short-term swing trade alerts newser.com Mon, 10 Nov 2025 09:34:07 GMT
• price action breakdown for protagonist therapeutics inc. - quarterly investment review & weekly high potential alerts newser.com Mon, 10 Nov 2025 09:22:22 GMT
• can protagonist therapeutics inc. hit a new high this month - july 2025 intraday action & daily chart pattern signals newser.com Mon, 10 Nov 2025 08:12:31 GMT
• will protagonist therapeutics inc. stock benefit from commodity prices - portfolio return report & smart money movement alerts newser.com Sun, 09 Nov 2025 13:10:40 GMT
• price action breakdown for protagonist therapeutics inc. - product launch & fast momentum entry tips newser.com Sun, 09 Nov 2025 12:28:22 GMT
• is protagonist therapeutics inc. stock entering bullish territory - 2025 price targets & low drawdown investment strategies newser.com Sun, 09 Nov 2025 08:23:56 GMT
• Protagonist Announces Icotrokinra Phase 2b ANTHEM-UC Trial Data to be Presented at the United European Gastroenterology Week Berli... The Daily News Journal Sun, 09 Nov 2025 07:52:25 GMT
• Protagonist Therapeutics (NASDAQ:PTGX) Posts Quarterly Earnings Results, Misses Estimates By $0.03 EPS MarketBeat Sun, 09 Nov 2025 03:55:22 GMT
• protagonist therapeutics banks on fda moves, despite mounting losses Finimize Sat, 08 Nov 2025 23:14:34 GMT
• Protagonist Therapeutics (NASDAQ:PTGX) Price Target Raised to $81.00 MarketBeat Sat, 08 Nov 2025 21:28:00 GMT
• Barclays Remains a Buy on Protagonist Therapeutics (PTGX) The Globe and Mail Sat, 08 Nov 2025 19:04:57 GMT
• Barclays Boosts Protagonist Therapeutics (NASDAQ:PTGX) Price Target to $88.00 MarketBeat Sat, 08 Nov 2025 18:27:11 GMT
• protagonist therapeutics announces oral and poster presentations on rusfertide at the 67th annual ash meeting Times Herald Sat, 08 Nov 2025 17:15:42 GMT
• Protagonist Therapeutics (NASDAQ:PTGX) Stock Price Expected to Rise, Citizens Jmp Analyst Says MarketBeat Sat, 08 Nov 2025 15:19:43 GMT
• a quick look at today's ratings for protagonist therapeutics(ptgx.us), with a forecast between $80 to $90 富途牛牛 Sat, 08 Nov 2025 13:00:00 GMT
• wedbush maintains protagonist therapeutics(ptgx.us) with buy rating, maintains target price $86 富途牛牛 Sat, 08 Nov 2025 11:40:35 GMT
• j.p. morgan maintains protagonist therapeutics(ptgx.us) with buy rating, raises target price to $81 富途牛牛 Sat, 08 Nov 2025 10:52:22 GMT
• Protagonist Therapeutics to Participate in Multiple Investment Bank Conferences in September 2025 Florida Today Sat, 08 Nov 2025 07:06:01 GMT
• Protagonist Therapeutics (PTGX) Valuation in Focus Following Rapid Share Price Gains simplywall.st Sat, 08 Nov 2025 05:42:33 GMT
• protagonist therapeutics stock price target raised to $91 at clear street by investing.com Investing.com South Africa Sat, 08 Nov 2025 00:39:54 GMT
• protagonist therapeutics inc. (ptgx) stock price | live quotes & charts | nsd StocksToTrade Sat, 08 Nov 2025 00:19:00 GMT
• Citizens Maintains Protagonist Therapeutics (PTGX) Market Outperform Recommendation Nasdaq Sat, 08 Nov 2025 00:11:00 GMT
• protagonist therapeutics announces oral and poster presentations on rusfertide at the 67th annual ash meeting Gainesville Sun Fri, 07 Nov 2025 21:21:08 GMT
• Protagonist Therapeutics (PTGX) Receives Updated Price Target fr GuruFocus Fri, 07 Nov 2025 15:27:41 GMT
• Protagonist Therapeutics price target raised to $102 from $69 at Citizens JMP TipRanks Fri, 07 Nov 2025 13:17:15 GMT
• a quick look at today's ratings for protagonist therapeutics(ptgx.us), with a forecast between $80 to $102 富途牛牛 Fri, 07 Nov 2025 13:00:01 GMT
• Protagonist Therapeutics price target raised to $88 from $72 at Barclays TipRanks Fri, 07 Nov 2025 12:41:22 GMT
• barclays maintains protagonist therapeutics(ptgx.us) with buy rating, raises target price to $88 富途牛牛 Fri, 07 Nov 2025 12:07:14 GMT
• Protagonist Therapeutics stock price target raised to $91 at Clear Street Investing.com Fri, 07 Nov 2025 10:58:11 GMT
• protagonist therapeutics price target raised to $91 from $74 at clear street TipRanks Fri, 07 Nov 2025 10:40:06 GMT
• how protagonist therapeutics inc. stock reacts to job market data - july 2025 opening moves & verified chart pattern signals newser.com Fri, 07 Nov 2025 10:23:35 GMT
• protagonist therapeutics banks on fda moves, despite mounting losses Finimize Fri, 07 Nov 2025 07:00:45 GMT
• price action breakdown for protagonist therapeutics inc. - july 2025 trade ideas & weekly high conviction trade ideas newser.com Fri, 07 Nov 2025 06:23:55 GMT
• protagonist therapeutics advances pipeline amid financial loss TipRanks Fri, 07 Nov 2025 05:30:35 GMT
• protagonist therapeutics inc. stock chart pattern explained - market risk summary & expert verified movement alerts newser.com Fri, 07 Nov 2025 03:19:11 GMT
• protagonist therapeutics reports q3 eps (62c), consensus (64c) TipRanks Fri, 07 Nov 2025 00:47:37 GMT
• protagonist therapeutics earnings beat by $0.01, revenue topped estimates Investing.com Fri, 07 Nov 2025 00:39:47 GMT
• The Bull Case For Protagonist Therapeutics (PTGX) Could Change Following Upcoming Rusfertide Phase 3 Data Presentation Sahm Fri, 07 Nov 2025 00:33:45 GMT
• protagonist therapeutics (ptgx) reports q3 loss, lags revenue estimates sharewise.com Fri, 07 Nov 2025 00:07:38 GMT
• ptgx exceeds q3 revenue expectations and advances key programs GuruFocus Thu, 06 Nov 2025 23:35:36 GMT
• protagonist therapeutics q3 net loss widens to $39.3 mln MarketScreener Thu, 06 Nov 2025 22:05:33 GMT
• protagonist reports third quarter 2025 financial results and provides corporate update ACCESS Newswire Thu, 06 Nov 2025 21:11:21 GMT
• how strong is protagonist therapeutics inc. stock revenue growth - analyst upgrade & risk adjusted buy/sell alerts newser.com Thu, 06 Nov 2025 11:30:23 GMT
• can protagonist therapeutics inc. hit a new high this month - dollar strength & low drawdown momentum trade ideas newser.com Thu, 06 Nov 2025 11:15:14 GMT
• Burney Co. Cuts Stock Position in Protagonist Therapeutics, Inc. $PTGX MarketBeat Thu, 06 Nov 2025 09:49:36 GMT
• how protagonist therapeutics inc. stock responds to policy changes - july 2025 recap & expert approved momentum ideas newser.com Thu, 06 Nov 2025 08:41:45 GMT
• Protagonist Therapeutics (PTGX) Reports Q3 Loss, Lags Revenue Estimates Yahoo Finance Thu, 06 Nov 2025 08:00:00 GMT
• Protagonist Therapeutics Advances Pipeline Amid Financial Loss TipRanks Thu, 06 Nov 2025 08:00:00 GMT
• Protagonist Therapeutics earnings beat by $0.01, revenue topped estimates Investing.com Thu, 06 Nov 2025 08:00:00 GMT
• Protagonist Therapeutics, Inc. $PTGX Shares Purchased by EFG Asset Management North America Corp. MarketBeat Thu, 06 Nov 2025 08:00:00 GMT
• Promising Developments and Strategic Progress at Protagonist Therapeutics Drive Buy Rating TipRanks Thu, 06 Nov 2025 08:00:00 GMT
• protagonist therapeutics reports q3 eps (62c), consensus (64c) TipRanks Thu, 06 Nov 2025 08:00:00 GMT
• earnings flash (ptgx) protagonist therapeutics, inc. reports q3 revenue $4.7m, vs. factset est of $3.8m MarketScreener Thu, 06 Nov 2025 08:00:00 GMT
• what insider trading reveals about protagonist therapeutics inc. stock - options play & long-term growth portfolio plans Fundação Cultural do Pará Thu, 06 Nov 2025 05:44:26 GMT
• Is Protagonist Therapeutics Inc. stock a top pick in earnings season - Buy Signal & Consistent Return Investment Signals newser.com Thu, 06 Nov 2025 05:30:55 GMT
• how rising interest rates impact protagonist therapeutics inc. stock - weekly stock report & high accuracy swing entry alerts newser.com Wed, 05 Nov 2025 22:42:49 GMT
• Protagonist Therapeutics to Participate in Multiple Investment Bank Conferences in September 2025 Daily Commercial Wed, 05 Nov 2025 17:24:57 GMT
• is protagonist therapeutics inc. stock entering bullish territory - 2025 growth vs value & weekly chart analysis and trade guides newser.com Wed, 05 Nov 2025 10:30:17 GMT
• protagonist therapeutics falls amid a report j&j deal price may be lower MSN Wed, 05 Nov 2025 10:04:23 GMT
• how strong is protagonist therapeutics inc. stock revenue growth - july 2025 drop watch & comprehensive market scan insights newser.com Wed, 05 Nov 2025 09:12:18 GMT
• is protagonist therapeutics inc. stock cheap compared to fundamentals - buy signal & accurate buy signal notifications newser.com Wed, 05 Nov 2025 08:27:25 GMT
• Bryce Point Capital LLC Invests $343,000 in Protagonist Therapeutics, Inc. $PTGX MarketBeat Wed, 05 Nov 2025 08:00:00 GMT
• can protagonist therapeutics inc. hit a new high this month - july 2025 analyst calls & verified momentum stock ideas newser.com Wed, 05 Nov 2025 07:51:23 GMT
• how protagonist therapeutics inc. stock reacts to job market data - 2025 top gainers & technical pattern alert system newser.com Wed, 05 Nov 2025 05:39:07 GMT
• is protagonist therapeutics inc. stock a top pick in earnings season - july 2025 analyst calls & real-time market sentiment report... newser.com Wed, 05 Nov 2025 03:57:53 GMT
• protagonist therapeutics stock gains 30% as j&j reportedly eyes deal MSN Wed, 05 Nov 2025 03:31:36 GMT
• how protagonist therapeutics inc. stock responds to policy changes - trade risk report & daily stock trend reports newser.com Tue, 04 Nov 2025 23:54:21 GMT
• rate hike: how buybacks impact protagonist therapeutics inc. stock value - july 2025 wrapup & smart allocation stock tips fcp.pa.gov.br Tue, 04 Nov 2025 21:33:51 GMT
• protagonist announces new icotrokinra data in ulcerative colitis and plaque psoriasis presented at two recent medical conferences Lansing State Journal Tue, 04 Nov 2025 18:13:38 GMT
• btig maintains protagonist therapeutics(ptgx.us) with buy rating, maintains target price $82 富途牛牛 Tue, 04 Nov 2025 15:34:00 GMT
• can protagonist therapeutics inc. stock outperform in 2025 bull market - weekly stock summary & low risk high reward trade ideas fcp.pa.gov.br Tue, 04 Nov 2025 11:49:38 GMT
• how rising interest rates impact protagonist therapeutics inc. stock - 2025 performance recap & high accuracy trade alerts newser.com Tue, 04 Nov 2025 09:15:13 GMT
• can protagonist therapeutics inc. hit a new high this month - quarterly earnings summary & real-time volume surge alerts newser.com Tue, 04 Nov 2025 08:55:38 GMT
• Protagonist Therapeutics (PTGX): Valuation Insights Ahead of Key Rusfertide Clinical Data at ASH Meeting Yahoo Finance Tue, 04 Nov 2025 08:00:00 GMT
• Hussman Strategic Advisors Inc. Sells 21,000 Shares of Protagonist Therapeutics, Inc. $PTGX MarketBeat Tue, 04 Nov 2025 08:00:00 GMT
• rusfertide receives breakthrough therapy designation for treatment of erythrocytosis in patients with polycythemia vera The Augusta Chronicle Tue, 04 Nov 2025 00:18:32 GMT
• can protagonist therapeutics inc. stock outperform in 2025 bull market - 2025 retail activity & long-term growth portfolio plans fcp.pa.gov.br Mon, 03 Nov 2025 22:22:57 GMT
• protagonist therapeutics announces oral and poster presentations on rusfertide at the 67th annual ash meeting ACCESS Newswire Mon, 03 Nov 2025 21:08:50 GMT
• Protagonist (PTGX) to present 4 rusfertide presentations at ASH, including Phase 3 VERIFY Stock Titan Mon, 03 Nov 2025 21:05:00 GMT
• protagonist therapeutics inc. stock chart pattern explained - market risk summary & fast moving market watchlists newser.com Mon, 03 Nov 2025 13:37:20 GMT
• how rising interest rates impact protagonist therapeutics inc. stock - 2025 key lessons & reliable breakout forecasts newser.com Mon, 03 Nov 2025 12:59:56 GMT
• is protagonist therapeutics inc. stock entering bullish territory - wall street watch & expert curated trade ideas newser.com Mon, 03 Nov 2025 11:34:07 GMT
• leerink partnrs issues optimistic forecast for ptgx earnings MarketBeat Mon, 03 Nov 2025 07:21:42 GMT
• can protagonist therapeutics inc. hit a new high this month - 2025 earnings impact & short-term high return ideas newser.com Mon, 03 Nov 2025 02:13:37 GMT
• how rising interest rates impact protagonist therapeutics inc. stock - weekly stock report & high accuracy trade alerts newser.com Sun, 02 Nov 2025 22:36:21 GMT
• Is Protagonist Therapeutics Still a Good Value After Doubling in 2025? simplywall.st Sun, 02 Nov 2025 20:26:15 GMT
• how strong is protagonist therapeutics inc. stock revenue growth - 2025 momentum check & safe capital preservation plans newser.com Sun, 02 Nov 2025 19:44:14 GMT
• price action breakdown for protagonist therapeutics inc. - july 2025 recap & free fast gain swing trade alerts newser.com Sun, 02 Nov 2025 18:33:52 GMT
• is protagonist therapeutics inc. stock entering bullish territory - stop loss & long-term safe investment ideas newser.com Sun, 02 Nov 2025 07:59:27 GMT
• can protagonist therapeutics inc. hit a new high this month - 2025 dividend review & weekly market pulse updates newser.com Sun, 02 Nov 2025 07:35:03 GMT
• protagonist announces icotrokinra phase 2b anthem-uc trial data to be presented at the united european gastroenterology week berli... The Marion Star Sun, 02 Nov 2025 00:49:22 GMT
• can protagonist therapeutics inc. hit a new high this month - july 2025 endofmonth & reliable price action trade plans newser.com Sat, 01 Nov 2025 16:54:16 GMT
• price action breakdown for protagonist therapeutics inc. - global markets & low risk growth stock ideas newser.com Sat, 01 Nov 2025 08:42:59 GMT
• Protagonist Therapeutics, Inc. $PTGX is Moody Aldrich Partners LLC's 2nd Largest Position MarketBeat Sat, 01 Nov 2025 07:00:00 GMT
• how protagonist therapeutics inc. stock responds to policy changes - 2025 macro impact & free daily entry point trade alerts newser.com Sat, 01 Nov 2025 06:08:07 GMT
• is protagonist therapeutics inc. stock a top pick in earnings season - weekly stock report & real-time sentiment analysis newser.com Sat, 01 Nov 2025 05:16:24 GMT
• protagonist announces icotrokinra phase 2b anthem-uc trial data to be presented at the united european gastroenterology week berli... Donaldsonville Chief Sat, 01 Nov 2025 02:23:24 GMT
• how strong is protagonist therapeutics inc. stock revenue growth - market sentiment report & growth focused stock reports newser.com Fri, 31 Oct 2025 11:06:50 GMT
• protagonist therapeutics inc. stock chart pattern explained - earnings growth summary & stepwise swing trade plans newser.com Fri, 31 Oct 2025 10:52:08 GMT
• how rising interest rates impact protagonist therapeutics inc. stock - 2025 breakouts & breakdowns & safe investment capital prese... newser.com Fri, 31 Oct 2025 10:11:37 GMT
• will protagonist therapeutics inc. stock benefit from commodity prices - product launch & daily entry point alerts newser.com Fri, 31 Oct 2025 07:28:18 GMT
• Protagonist Therapeutics (PTGX) to Release Earnings on Thursday MarketBeat Fri, 31 Oct 2025 07:00:00 GMT
• how protagonist therapeutics inc. stock reacts to job market data - 2025 market outlook & expert curated trade setups newser.com Fri, 31 Oct 2025 05:59:57 GMT
• is protagonist therapeutics inc. stock a top pick in earnings season - 2025 analyst calls & ai driven stock reports newser.com Fri, 31 Oct 2025 05:31:11 GMT
• is protagonist therapeutics inc. stock entering bullish territory - july 2025 retail & consistent profit trade alerts newser.com Fri, 31 Oct 2025 05:15:34 GMT
• price action breakdown for protagonist therapeutics inc. - weekly market summary & free safe entry trade signal reports newser.com Fri, 31 Oct 2025 04:36:58 GMT
• how protagonist therapeutics inc. stock responds to policy changes - july 2025 decliners & short-term trading opportunity alerts newser.com Fri, 31 Oct 2025 04:28:47 GMT
• protagonist announces new icotrokinra data in ulcerative colitis and plaque psoriasis presented at two recent medical conferences Florida Today Thu, 30 Oct 2025 16:23:18 GMT
• Protagonist Therapeutics (PTGX): Assessing Valuation After Breakthrough Phase 2b Results and Johnson & Johnson’s Phase 3 Launch Sahm Thu, 30 Oct 2025 15:00:00 GMT
• can protagonist therapeutics inc. hit a new high this month - market risk summary & long-term capital growth ideas newser.com Thu, 30 Oct 2025 11:06:30 GMT
• how protagonist therapeutics inc. stock reacts to job market data - weekly profit recap & stepwise trade signal guides newser.com Thu, 30 Oct 2025 10:58:40 GMT
• how protagonist therapeutics inc. stock responds to policy changes - 2025 market sentiment & free ai powered buy and sell recommen... newser.com Thu, 30 Oct 2025 09:03:36 GMT
• will protagonist therapeutics inc. stock benefit from commodity prices - quarterly portfolio review & advanced swing trade entry p... newser.com Thu, 30 Oct 2025 07:47:46 GMT
• Protagonist Therapeutics (PTGX) Expected to Beat Earnings Estimates: Should You Buy? Yahoo Finance Thu, 30 Oct 2025 07:00:00 GMT
Protagonist Therapeutics, Inc(NASDAQ:PTGX) 
Protagonist Therapeutics, Inc., a clinical-stage biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address unmet medical needs. It is developing PTG-300, an injectable hepcidin mimetic that is in Phase II clinical trial for the treatment of patients with polycythem...
Website: http://www.protagonist-inc.com
Founded: 2006
Full Time Employees: 76
Sector: Healthcare
Industry: Biotechnology